洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR-IPC-15006618】膝關節手法治療對退化性膝關節炎的效用

基本信息
登记号

ChiCTR-IPC-15006618

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2015-06-17

临床申请受理号

/

靶点

/

适应症

knee osteoarthritis

试验通俗题目

膝關節手法治療對退化性膝關節炎的效用

试验专业题目

膝關節手法治療對退化性膝關節炎的效用

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

膝關節手法治療對退化性膝關節炎的效用

试验分类
试验类型

随机平行对照

试验分期

其它

随机化

1:1 Randomization

盲法

/

试验项目经费来源

Hong Kong College of Family Physicians

试验范围

/

目标入组人数

104

实际入组人数

/

第一例入组时间

2015-06-30

试验终止时间

1990-01-01

是否属于一致性

/

入选标准

1) Aged ≥ 45 to ≤ 75 years old; 2) Diagnosis of knee OA based on clinical criteria as defined by the American Rheumatology Association; 3) Have experienced moderate to severe knee pain for at least 3 months, defined as a score of 3 or more (0-6 ordinal response scale) on the question “What is the average level of your left/right knee pain?” 4) Involvement of anterior knee compartment and exhibit 2 of the following criteria on initial assessment: pain on direct compression of the patella against the femoral condyles with the knee in full extension, tenderness on palpation of the posterior surface of the patella, pain on resisted knee extension, and pain with isometric quadriceps contraction against suprapatellar resistance with the knee in slight flexion.;

排除标准

1) Previous operation either open or arthroscopic, on the referring knee 2) Body mass index ≥ 35 kg/m2 3) Any knee injections within 1 month 4) Inflammatory or post-infectious knee arthritis 5) Daily use of opioid medication 6) Co-morbidity severe enough to prevent participation in the study protocol like attendance at scheduled appointments 7) Fixed flexion deformity >5 degree and varus and valgus deformity > 15 degree made manual mobilization of the patella impossible.;

研究者信息
研究负责人姓名
试验机构

Professor Regina Wing Shan SIT

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

Division of Family Medicine and Primary Health Care, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品